Gilead Stock News

Gilead Sciences, Inc. (GILD) with the stream of 1.33% also noticed, India Altice USA, Inc. (ATUS) encountered a rapid change of -2.55% in the last hour of Fridays trading session. The post Market Mover: Gilead Sciences, Inc. (NASDAQ:GILD), Altice USA, Inc. (NYSE:ATUS) appeared first on Stocks Equity .

Trust Co. of Toledo NA OH lowered its stake in Gilead Sciences, Inc. (NASDAQ:GILD) by 3.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,597 shares of the biopharmaceutical companys stock after selling 700 shares during the period. Trust Co. of []

IFP Advisors Inc lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 4.4% during the 3rd quarter, Holdings Channel.com reports. The firm owned 9,244 shares of the biopharmaceutical companys stock after acquiring an additional 390 shares during the period. IFP Advisors Incs holdings in Gilead Sciences were worth $645,000 at the end of []

Pensionfund DSM Netherlands purchased a new position in Gilead Sciences, Inc. (NASDAQ:GILD) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 18,000 shares of the biopharmaceutical companys stock, valued at approximately $1,257,000. Other institutional investors and hedge funds have also recently bought and []

Gilead Sciences (NASDAQ:GILD) was upgraded by equities research analysts at BMO Capital Markets from a market perform rating to an outperform rating in a research report issued on Thursday, Analyst Ratings Network reports. The firm currently has a $85.00 price target on the biopharmaceutical companys stock, up from their prior price target of $72.00. BMO []

Louisiana State Employees Retirement System lessened its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 0.1% in the third quarter, HoldingsChannel.com reports. The firm owned 142,900 shares of the biopharmaceutical companys stock after selling 200 shares during the period. Louisiana State Employees Retirement Systems holdings in Gilead Sciences were worth $9,981,000 as of its []

Iowa State Bank increased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 2.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 39,038 shares of the biopharmaceutical companys stock after buying an additional 899 shares during the period. Iowa State Banks holdings in []

(RTTNews) - Pharmaceutical firm Gilead Sciences, Inc. (GILD), on Friday, said it has submitted a Biologics License Application or BLA, to the U.S. Food and Drug Administration or FDA, for bulevirtide 2 mg injection, a potential first-in-class antiviral medicine for the treatment of chronic hepatitis delta virus or HDV infection in adults with

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for bulevirtide for injection (2 mg), a potential first-in-class antiviral medicine for the treatment of chronic hepatitis delta virus (HDV) infection in adults with compensated liver disease; bulevirtide has been granted Breakthrough Therapy and Orphan Drug designations by the FDA. Bulevirtide is an

Gilead Sciences Inc (NASDAQ: GILD) has submitted a marketing application to FDA for bulevirtide for injection (2 mg) for chronic hepatitis delta virus (HDV) infection in adults with compensated liv

Gilead (GILD) exercises options to Arcus' anti-TIGIT Program (domvanalimab and AB308), etrumadenant (A2a/A2b Adenosine Receptor Antagonist), and quemliclustat (small Molecule CD73 Inhibitor).

Guild Esports plc (LON:GILD), a global teams organisation and lifestyle brand, has announce the signing of Lennard Sill (Rezon) as the newest member of its Fortnite team. Rezon, from Germany, is a 17-time tournament winner with earnings of over $300,000. He has consistently ranked within the top 10 in Fortnite Champion Series (FNCS) tournaments this []

Europe Pharmaceutical Market: Overview The Europe pharmaceutical market has been anticipated to grow at a significant speed in the forthcoming years. This market has been driven by the rising rate of healthcare expenditure, the emergence of biosimilars and biologics, and increasing